Jeffrey krasner

Jeffrey Krasner a communications professional with a specialty in life sciences and early-stage companies. Most recently he was senior vice president at Slowey McManus Communications, a strategic communications firm in Boston. Previously, Jeff had his own firm, Emerging BioCommunications, which advised life science companies, venture funds and health care providers on communications, marketing, social media, media relations and crisis communications. 

 

Mr. Krasner previously served as Senior Director of Communications for Flagship Pioneering, a $14 billion venture fund investing in and creating new companies in therapeutics, health technologies and sustainability. He also served as Director of Corporate Communications for ARIAD Pharmaceuticals Inc., a commercial stage Cambridge biotechnology firm developing cancer therapeutics.

 

Mr. Krasner worked as a financial reporter in Boston for 25 years, writing about healthcare, biotechnology, commercial real estate, technology and autos. He served as a staff reporter at The Boston Globe for eight years. Earlier, he served as a staff reporter at The Wall Street Journal and the Boston Herald. His writing has appeared in numerous newspapers and magazines, and has been recognized with regional and national awards. 

 

Mr. Krasner is a frequent speaker at life science conferences and a sought-after moderator for panel discussions and other events. 

 

Mr. Krasner holds an M.A. in Journalism from the University of Missouri and a B.A. in Economics from Brandeis University. He lives in Watertown with his wife and non-running Citroen.